BASKING RIDGE, N.J., Feb 20, 2009 -- Hooper Holmes, Inc. (NYSE Alternext:HH) today announced that the President of its Health and Wellness Division, Christopher J. Behling, will be presenting at the Ninth Population Health and Disease Management Colloquium on Tuesday, March 3, 2009 at 9:00 a.m. The conference is being held at the Hyatt Regency at Penn's Landing in Philadelphia, Pennsylvania.
Mr. Behling's presentation, entitled "Biometric and Lab Screenings: Debunking the Myths to Unlock the Power of Total Population Health Management," will discuss the role of screenings in total population health, common screening myths and misconceptions, and enabling total population health management.
Chris Behling commented, "People are living longer but not necessarily healthier due to chronic diseases. In order to control chronic diseases that affect so many people, it is essential that we better understand the health risks of the total population. Biometric and lab data are key to uncovering these unknown risks and reducing future costs. We look forward to sharing our experiences with our customers and colleagues in the Disease Management industry."
About Hooper Holmes Health and Wellness
Hooper Holmes Health and Wellness service is a "one-stop shop" for wellness and disease management companies, providing scheduling support, fulfillment of supplies, blood collection kits, medical screenings, lab testing, and data transmission. As a result, these companies can now reach more participants, gather more participant data earlier in the disease management process, better target interventional health support services and more easily reach participants on their terms, at work or at home.
About Hooper Holmes
Hooper Holmes is the leader in collecting personal health data and transforming it into useful information, enabling customers to take actions that manage or reduce their risks and expenses. As the leading provider of risk assessment services for the insurance industry, Hooper Holmes provides insurers with the widest range of medical exam, data collection, laboratory testing and underwriting services in the industry.
With presence in over 250 markets and a network of thousands of examiners, Hooper Holmes can arrange a medical exam anywhere in the U.S. and deliver the results to its customers. Each year we arrange more medical exams than any other company and process 3.8 million specimens in our laboratory. We provide a complete service for wellness, disease management, and managed care companies including scheduling support, fulfillment of supplies, blood collection kits, medical screenings, lab testing and data transmission. We underwrite 300,000 cases annually and complete more than two million telephone interviews. We are also a leading provider of medical claims evaluation services used by property and casualty insurance carriers, law firms, self-insureds and third-party administrators to handle personal injury and accident claims.
This press release contains "forward-looking" statements, as such term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements included in this press release include, without limitation, the expected reductions in expenses through productivity improvements. These forward-looking statements are based on the Company's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions. Among the important factors that could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements are our ability to successfully implement our business strategy; uncertainty as to our working capital requirements over the next 12 to 24 months; our ability to maintain compliance with the financial covenants in our credit facility; our expectations regarding our operating cash flows; and the rate of life insurance application activity. Additional information about these and other factors that could affect the Company's business is set forth in the Company's annual report on Form 10-K for the year ended December 31, 2007, filed with the Securities and Exchange Commission on March 14, 2008. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release to reflect the occurrence of unanticipated events, except as required by law.